The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 182K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bánfi, B.
Right arrow Articles by Demaurex, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bánfi, B.
Right arrow Articles by Demaurex, N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1999/7/183/ $5.00
The Journal of Experimental Medicine, Volume 190, Number 2, July 19, 1999 183-194


Original Article

A Novel H+ Conductance in Eosinophils: Unique Characteristics and Absence in Chronic Granulomatous Disease



Botond Bánfia,c, Jacques Schrenzela, Oliver Nüssea, Daniel P. Lewa, Erzsébet Ligetic, Karl-Heinz Krauseb, and Nicolas Demaurexd

a From the Division of Infectious Diseases, Geneva University Hospitals, CH-1211 Geneva 4, Switzerland
b From the Department of Geriatrics, Geneva University Hospitals, CH-1211 Geneva 4, Switzerland
c Department of Physiology, Semmelweis Medical University, H-1444 Budapest, Hungary
d Department of Physiology, University of Geneva, CH-1211 Geneva 4, Switzerland
Department of Physiology, University of Geneva Medical Center, 1, Michel-Servet, CH-1211 Geneva 4, Switzerland.41-22-702-540241-22-702-5399

Nicolas.Demaurex{at}medecine.unige.ch

Efficient mechanisms of H+ ion extrusion are crucial for normal NADPH oxidase function. However, whether the NADPH oxidase—in analogy with mitochondrial cytochromes—has an inherent H+ channel activity remains uncertain: electrophysiological studies did not find altered H+ currents in cells from patients with chronic granulomatous disease (CGD), challenging earlier reports in intact cells. In this study, we describe the presence of two different types of H+ currents in human eosinophils. The "classical" H+ current had properties similar to previously described H+ conductances and was present in CGD cells. In contrast, the "novel" type of H+ current had not been described previously and displayed unique properties: (a) it was absent in cells from gp91- or p47-deficient CGD patients; (b) it was only observed under experimental conditions that allowed NADPH oxidase activation; (c) because of its low threshold of voltage activation, it allowed proton influx and cytosolic acidification; (d) it activated faster and deactivated with slower and distinct kinetics than the classical H+ currents; and (e) it was ~20-fold more sensitive to Zn2+ and was blocked by the histidine-reactive agent, diethylpyrocarbonate (DEPC). In summary, our results demonstrate that the NADPH oxidase or a closely associated protein provides a novel type of H+ conductance during phagocyte activation. The unique properties of this conductance suggest that its physiological function is not restricted to H+ extrusion and repolarization, but might include depolarization, pH-dependent signal termination, and determination of the phagosomal pH set point.

Key Words: proton conductance • NADPH oxidase • granulomatous disease • hydrogen ion concentration • eosinophils


1used in this paper: CGD, chronic granulomatous disease; DEPC, diethylpyrocarbonate; DPI, diphenyliodinium; EH+ and EK+, H+ and K+ equilibrium potential; Erev, reversal potential of the current; pHi, intracellular pH; pHo, extracellular pH; TEACl, tetraethyl ammonium chloride

J. Schrenzel's present address is Department of Clinical Microbiology, Mayo Clinic, Rochester, MN.

© 1999 The Rockefeller University Press


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS